MFS
IBRX icon

Mirabella Financial Services’s ImmunityBio IBRX Stock Holding History

Mirabella Financial Services’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,641
Closed -$151K – 917
2026
Q1 		$151K Buy
+19,641
New +$134K 0.01% 821
2020
Q4 		– Sell
-22,902
Closed -$159K – 391
2020
Q3 		$159K Buy
+22,902
New +$228K 0.02% 301

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirabella Financial Services's IBRX Position: Q2 2026 in Review

Mirabella Financial Services sold out of ImmunityBio (IBRX) in Q2 2026, closing a stake of 19,641 shares — an estimated $151K sold.

Mirabella Financial Services first reported a position in IBRX in Q3 2020 and held it in 2 quarters. The position peaked at $159K in Q3 2020. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Mirabella Financial Services reported no remaining ImmunityBio position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 19,641 ImmunityBio shares in Q2 2026, an estimated $151K.
  • Mirabella Financial Services first reported a position in ImmunityBio in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's ImmunityBio position peaked at $159K in Q3 2020.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.